epirubicin "seacross" 2 mg/ml injektionsvæske, opløsning
seacross pharmaceuticals ltd - epirubicinhydrochlorid - injektionsvæske, opløsning - 2 mg/ml
plerixafor "seacross" 20 mg/ml injektionsvæske, opløsning
seacross pharma (europe) limited - plerixafor - injektionsvæske, opløsning - 20 mg/ml
vivotif 2 mia bakterier enterokapsler, hårde
paxvax ltd. - salmonella typhi stamme ty 21a berna, frysetørret (levende) - enterokapsler, hårde - 2 mia bakterier
mizuki emulsionskoncentrat
nichino europe limited - pyraflufen-ethyl, pyraflufen - emulsionskoncentrat - 10,6 g/l pyraflufen-ethyl ; (~ 9,88 g/l pyraflufen)
mizuki, reg.nr. 604-34 (kartofler 2022) emulsionskoncentrat
belchim crop protection nv/sa - pyraflufen-ethyl, pyraflufen - emulsionskoncentrat - 10,6 g/l pyraflufen-ethyl ; (~ 9,88 g/l pyraflufen
lumoxiti
astrazeneca ab - moxetumomab pasudotox - leukæmi, hårete celler - antineoplastiske midler - lumoxiti as monotherapy is indicated for the treatment of adult patients with relapsed or refractory hairy cell leukaemia (hcl) after receiving at least two prior systemic therapies, including treatment with a purine nucleoside analogue (pna).
solymbic
amgen europe b.v. - adalimumab - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - immunosuppressiva - se venligst afsnit 4. 1 i resuméet af produktegenskaber i produktinformationsdokumentet.
carvedilol "aurobindo" 12,5 mg filmovertrukne tabletter
aurobindo pharma (malta) limited - carvedilol - filmovertrukne tabletter - 12,5 mg
carvedilol "aurobindo" 25 mg filmovertrukne tabletter
aurobindo pharma (malta) limited - carvedilol - filmovertrukne tabletter - 25 mg
carvedilol "aurobindo" 6,25 mg filmovertrukne tabletter
aurobindo pharma (malta) limited - carvedilol - filmovertrukne tabletter - 6,25 mg